The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug

SM Johnson, S Connelly, C Fearns, ET Powers… - Journal of molecular …, 2012 - Elsevier
Transthyretin (TTR) is one of the many proteins that are known to misfold and aggregate (ie,
undergo amyloidogenesis) in vivo. The process of TTR amyloidogenesis causes nervous …
被引用次数：369 相关文章

The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug

SM Johnson, S Connelly, C Fearns, ET Powers… - Journal of Molecular …, 2012 - infona.pl
Transthyretin (TTR) is one of the many proteins that are known to misfold and aggregate (ie,
undergo amyloidogenesis) in vivo. The process of TTR amyloidogenesis causes nervous …

The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug

SM Johnson, S Connelly, C Fearns… - Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Transthyretin (TTR) is one of the many proteins that are known to misfold and aggregate (ie,
undergo amyloidogenesis) in vivo. The process of TTR amyloidogenesis causes nervous …

[引用][C] The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug

SM Johnson, S Connelly, C Fearns… - Journal of Molecular …, 2012 - cir.nii.ac.jp
The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation
Linked to Pathology to a Regulatory-Agency-Approved Drug | CiNii Research CiNii 国立情報学 …
[HTML] nih.gov

[HTML][HTML] The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory Agency Approved Drug

SM Johnson, S Connelly, C Fearns… - Journal of Molecular …, 2012 - ncbi.nlm.nih.gov
Transthyretin (TTR) is one of the many proteins that are known to misfold and aggregate (ie,
undergo amyloidogenesis) in vivo. The process of TTR amyloidogenesis causes nervous …

The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

SM Johnson, S Connelly, C Fearns… - Journal of Molecular …, 2012 - europepmc.org
Transthyretin (TTR) is one of the many proteins that are known to misfold and aggregate (ie,
undergo amyloidogenesis) in vivo. The process of TTR amyloidogenesis causes nervous …

The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

SM Johnson, S Connelly, C Fearns… - Journal of Molecular …, 2012 - europepmc.org
Transthyretin (TTR) is one of the many proteins that are known to misfold and aggregate (ie,
undergo amyloidogenesis) in vivo. The process of TTR amyloidogenesis causes nervous …

[引用][C] The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug

SM Johnson, S Connelly, C Fearns, ET Powers… - 2012